Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) outbreak in Wuhan, China, was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anisodamine hydrobromide injection (AHI), the main ingredient of which is anisodamine, is a listed drug for improving microcirculation in China. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jinsong, Liu, Zixuan, Liu, Chuan, Li, Xuanhao, Wang, Yi, Zhao, Jing, Wu, Qingjiang, Zheng, Shichao, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411467/
https://www.ncbi.nlm.nih.gov/pubmed/32802131
http://dx.doi.org/10.1155/2020/5818107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411467/
https://www.ncbi.nlm.nih.gov/pubmed/32802131
http://dx.doi.org/10.1155/2020/5818107

Ejemplares similares